Latest News

Roche to showcase latest innovations in diagnostic solutions at American Association of Clinical Chemistry 2022 Clinical Lab Expo

  • The exhibit booth will highlight solutions that offer new ways to tackle today’s most complex lab challenges and deliver better patient care.

  • Roche will debut the Idea Lab series, where industry experts will share insights on healthcare topics such as health equity, access, workforce stress and data optimization.

Indianapolis And Chicago, July 22, 2022 /PRNewswire/ — Roche (SIX: RO,ROG) (OTCQX: RHHBY) will showcase a state-of-the-art interactive and solution-focused exhibit at the 2022 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo, July 24-28 inside Chicago.

Roche logo (PRNewsfoto/Roche)

Roche logo (PRNewsfoto/Roche)

The Roche exhibition booth (No. 2002) will showcase the latest solutions that can connect laboratory systems, analyze data and drive new efficiencies so labs have more time to focus on providing better patient care. To address current laboratory challenges, Roche will launch the Roche Idea Lab, where experts in areas critical to laboratory success will provide key insights. These areas include health equity and access to testing, staffing stress, data optimization, and the lab’s success in improving clinical outcomes for patients with cardiometabolic, neurodegenerative, and infectious diseases.

“Laboratorians want to focus on the tasks that matter most, delivering results that impact lives. There is a critical need for solutions that reduce staff stress and improve testing capacity and access,” said Matte sauce, president and CEO of Roche Diagnostics North America. “Addressing these challenges together is essential to delivering patient care, and our Roche booth will showcase innovative and integrated solutions that meet these needs.”

The Roche exhibition booth will showcase 18 innovative systems including:

  • cobas® Pro and cobas® Pure* serum work area solutions

  • cobas® 5800* Molecular System

  • cobas® Pulse*, a point-of-care professional glucose management solution

*Product not available for sale pending US Food and Drug Administration 510(k) submission.

Roche will also present 11 interactive workshops as part of the Idea Lab to share best practices and provide answers to the most pressing issues in today’s evolving lab environment. For more information on the 2022 AACC and Roche’s participation in the Idea Lab program, see This year participation is both virtual and in person.

Featured sessions include:

Tuesday, July 26

Apprenticeship programs to help fill staffing shortages 10:00 – 10:30 am CDT
Cecilia M. ThompsonMS, Ph.D., Medical Director, Infectious Diseases, Tricor Reference Laboratories

NaviFi’s Digital Ecosystem: The Future of Healthcare | 10:45 – 11:15 am CDT
Nam K. tran, PhD, Director, Pathology Biorepository; Professor, Department of Clinical Pathology, UC Davis Health

Heart failure from sugar spikes in type II diabetes 11:30 am – 12:30 pm CDT
panelists from University of Texas Southwestern Medical Center And University of California, San Francisco

Inclusion by Design: How Labs Can Drive Health Equity and Access 1:00 – 1:45 pm CDT
Gary Pukrien, Ph.D., President and CEO, National Minority Quality Forum
Octavia Peck PalmerPh.D., Assistant Professor of Critical Care Medicine, University of Pittsburgh School of Medicine; President-Elect, American Association of Clinical Chemistry

Successful change happens with people 2:15 – 2:45 pm CDT
Jennifer LambSystems Implementation Program Director, Roche Diagnostics

Antimicrobial stewardship in the emergency department 3:00 – 3:45 pm CDT
Larissa May, MD, Director of Emergency Department and Outpatient Antibiotic Stewardship, UC Davis Health; Antibiotic Stewardship Lead, VA Northern California Health Care System

Wednesday, July 27

A unique approach to training to help meet staffing shortages 10:00 – 10:30 am CDT
A panel from Wisconsin Diagnostic Laboratories

Insights and Implications for Home Testing and Self-Collection | 11:30 am – 12:30 pm CDT
Tricor Reference Laboratory panelists, University of Washington School of Medicine and St. Louis County Sexual Health Clinic, Seattle Children’s Hospital and Massachusetts General hospital

Structure, Strategy and People: How Roche Healthcare Consulting Helps Optimize Your Testing Menu 1:00 – 1:30 pm CDT
A panel from Roche Healthcare Consulting

Optimize workflow and personnel with cobas® infinity 2:00 – 2:30 pm CDT
Jim DollsSystems Manager, Laboratory, Iowa Methodist Medical Center, UnityPoint Health – of monks

Automation: Solutions for Now, Vision for the Future | 2:00 – 2:30 pm CDT
A panel from Wisconsin Diagnostic Laboratories and UnityPoint Health

About Roche

Roche is a global leader in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics, as well as growing capabilities in data-driven medical insights, help Roche deliver truly personalized healthcare. Roche is working with partners across the healthcare sector to deliver the best care for every individual.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and central nervous system diseases. Roche is also a world leader in in vitro diagnostics and tissue-based cancer diagnosis and a pioneer in diabetes management. In recent years, the company has invested in genomic profiling and real-world data partnerships and has become an industry-leading partner for medical insights.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat disease and make a sustainable contribution to society. The company aims to improve patient access to medical innovation by working with all relevant stakeholders. More than 30 medicines developed by Roche are included in the World Health Organization’s Model List of Essential Medicines, among them life-saving antibiotics, antimalarial and cancer drugs. Moreover, for the thirteenth consecutive year, Roche has been recognized as one of the most sustainable companies in the pharmaceutical industry by the Dow Jones Sustainability Indices (DJSI).

Group headquarters in Roche Basel, Switzerland, active in more than 100 countries and employing more than 100,000 people worldwide in 2020. In 2020, Roche invested CHF 12.2 billion R&D and post sales CHF 58.3 billion. Genetech, In United States, a wholly owned member of the Roche Group. Roche is the majority shareholder of Chugai Pharmaceuticals, Japan. Please visit for more information

All trademarks used or mentioned in this release are protected by law. cobas® Pulse and cobas® Pure are under development and not available for sale in the United States.

Roche Diagnostics US Media Relations

Jonathan Hosea
+1-317-287-9032 /

Closed Sites:
Jane Dial
+1-463-867-0232 /



To download multimedia visit original content: -clinical-lab-expo-301591649.html

Source Roche

Source link

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button